Skip to main content
MORN
NASDAQ Finance

Morningstar Q2 Revenue Tops Estimates, Operating Margin Expands to 24.2%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Positive
Importance info
7
Price
$198.66
Mkt Cap
$7.555B
52W Low
$141.49
52W High
$289.63
52W Position info
40% above low
Off High info
31% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

MORN sits 40% above its 52-week low of $141.49 on elevated volume (2.1× avg).

Summary

Morningstar posted Q2 revenue and earnings above expectations, with operating margin expanding to 24.2%. The company repurchased $400M in shares during H1, and the Executive Chairman adopted a pre-arranged stock sale plan.


Key Events · Earnings and Guidance · MORN

  • Q2 Revenue and Earnings Beat

    Revenue of $663.2M exceeded the $649.7M consensus; adjusted EPS of $3.10 beat estimates. Operating income rose 28.4% to $160.6M.

  • Operating Margin Expansion

    Operating margin improved to 24.2% from 20.7% a year ago, reflecting revenue growth and cost discipline.

  • Aggressive Share Repurchases

    Morningstar repurchased $400M in shares during H1 2026, with $300M remaining under its $1B buyback program.

  • Executive Chairman Adopts 10b5-1 Plan

    Joe Mansueto adopted a Rule 10b5-1 trading plan to sell up to 200,000 shares between June 2026 and April 2027.


Analysis · MORN · Finance

A strong second quarter saw Morningstar deliver revenue of $663.2 million, beating the $649.7 million consensus, while adjusted EPS of $3.10 handily topped estimates. Operating margin expanded 3.5 percentage points to 24.2%, fueled by broad-based revenue growth and disciplined cost management. The company continued its aggressive buyback, repurchasing $400 million in the first half, and Executive Chairman Joe Mansueto adopted a 10b5-1 plan to sell up to 200,000 shares. Although the results are solid, the stock is already near all-time highs, and the insider selling plan may temper enthusiasm.

At the time of this filing, MORN was trading at $198.66 on NASDAQ in the Finance sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $141.49 to $289.63. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MORN - Latest Insights

MORN
Jul 29, 2026, 4:37 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $198.66
Real-time Price: $198.66 info
Change: $0 (0%) info
Market Cap: $7.555B info
MORN
Jul 29, 2026, 4:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $198.66
Real-time Price: $198.66 info
Change: $0 (0%) info
Market Cap: $7.555B info
MORN
Jun 25, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $141.84
Real-time Price: $198.66 info
Change: +$56.82 (+40%) info
Market Cap: $7.555B info
MORN
May 22, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $179.64
Real-time Price: $198.66 info
Change: +$19.02 (+11%) info
Market Cap: $7.555B info
MORN
Apr 29, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $187.60
Real-time Price: $198.66 info
Change: +$11.06 (+6%) info
Market Cap: $7.555B info